Article info
PDFChronic obstructive pulmonary disease
Original article
Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
- Correspondence to Professor Emma H Baker, Institute for Infection and Immunity, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK; ebaker{at}sgul.ac.uk
Citation
Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial
Publication history
- Received November 5, 2015
- Revised January 25, 2016
- Accepted January 29, 2016
- First published February 25, 2016.
Online issue publication
September 01, 2022
Article Versions
- Previous version (7 October 2016).
- Previous version (7 October 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/